Detalhe da pesquisa
1.
Red blood cell-derived arginase release in hemolytic uremic syndrome.
J Transl Med
; 22(1): 17, 2024 Jan 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38178089
2.
Complement dysregulation associated with a genetic variant in factor H-related protein 5 in atypical hemolytic uremic syndrome.
Pediatr Nephrol
; 39(4): 1105-1111, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-37955705
3.
Aliskiren inhibits renin-mediated complement activation.
Kidney Int
; 94(4): 689-700, 2018 10.
Artigo
Inglês
| MEDLINE | ID: mdl-29884545
4.
Early Terminal Complement Blockade and C6 Deficiency Are Protective in Enterohemorrhagic Escherichia coli-Infected Mice.
J Immunol
; 197(4): 1276-86, 2016 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-27421478
5.
C1-Inhibitor Decreases the Release of Vasculitis-Like Chemotactic Endothelial Microvesicles.
J Am Soc Nephrol
; 28(8): 2472-2481, 2017 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-28289183
6.
A novel mechanism of bacterial toxin transfer within host blood cell-derived microvesicles.
PLoS Pathog
; 11(2): e1004619, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25719452
7.
Shiga toxin-induced complement-mediated hemolysis and release of complement-coated red blood cell-derived microvesicles in hemolytic uremic syndrome.
J Immunol
; 194(5): 2309-18, 2015 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25637016
8.
The combined role of galactose-deficient IgA1 and streptococcal IgA-binding M Protein in inducing IL-6 and C3 secretion from human mesangial cells: implications for IgA nephropathy.
J Immunol
; 193(1): 317-26, 2014 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-24850720
9.
Complement activation associated with ADAMTS13 deficiency in human and murine thrombotic microangiopathy.
J Immunol
; 191(5): 2184-93, 2013 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-23878316
10.
Complement Interactions with Blood Cells, Endothelial Cells and Microvesicles in Thrombotic and Inflammatory Conditions.
Adv Exp Med Biol
; 865: 19-42, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26306441
11.
A novel C3 mutation causing increased formation of the C3 convertase in familial atypical hemolytic uremic syndrome.
J Immunol
; 188(4): 2030-7, 2012 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-22250080
12.
Eculizumab in an anephric patient with atypical haemolytic uraemic syndrome and advanced vascular lesions.
Nephrol Dial Transplant
; 28(11): 2899-907, 2013 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-24009284
13.
Genetic investigation of Nordic patients with complement-mediated kidney diseases.
Front Immunol
; 14: 1254759, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37744338
14.
Thrombotic microangiopathy mimicking membranoproliferative glomerulonephritis.
Nephrol Dial Transplant
; 32(3): 584, 2017 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28168280
15.
IgG Binds Escherichia coli Serine Protease EspP and Protects Mice From E. coli O157:H7 Infection.
Front Immunol
; 13: 807959, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35250980
16.
Apyrase decreases phage induction and Shiga toxin release from E. coli O157:H7 and has a protective effect during infection.
Gut Microbes
; 14(1): 2122667, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36138514
17.
Thrombotic microangiopathy mimicking membranoproliferative glomerulonephritis.
Nephrol Dial Transplant
; 26(10): 3399-403, 2011 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-21810760
18.
Factor D Inhibition Blocks Complement Activation Induced by Mutant Factor B Associated With Atypical Hemolytic Uremic Syndrome and Membranoproliferative Glomerulonephritis.
Front Immunol
; 12: 690821, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34177949
19.
Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation.
Blood
; 111(11): 5307-15, 2008 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-18268093
20.
Shiga Toxin-Bearing Microvesicles Exert a Cytotoxic Effect on Recipient Cells Only When the Cells Express the Toxin Receptor.
Front Cell Infect Microbiol
; 10: 212, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32523894